paclitaxel has been researched along with Xerostomia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarado Miranda, A; Astudillo de la Vega, H; Bargalló Rocha, E; de la Rosa Oliva, F; Flores-Díaz, D; Gutiérrez-Salmeán, G; Ibarra, A; Lara-Medina, F; Matus-Santos, J; Meneses García, A; Oñate-Acuña, LF; Ruiz Calzada, H; Ruiz García, E | 1 |
| Allen, A; Braschayko, P; Burke, E; Costello, R; Flynn, J; Haddad, R; Li, Y; Mahadevan, A; Posner, M; Sonis, S; Tishler, RB; Wirth, L | 1 |
| Balboni, TA; Haddad, RI; Norris, CM; Posner, MR; Schoenfeld, JD; Sher, DJ; Tishler, RB | 1 |
| Braaksma, M; Levendag, P | 1 |
| Costello, R; Haddad, R; Posner, M; Weeks, L; Wirth, L | 1 |
| Christie, D; Kennedy, T; Law, A; Pellitteri, P; Wood, C; Yumen, O | 1 |
5 trial(s) available for paclitaxel and Xerostomia
| Article | Year |
|---|---|
Effects of omega-3 fatty acids supplementation on neoadjuvant chemotherapy-induced toxicity in patients with locally advanced breast cancer: a randomized, controlled, double-blinded clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Glucose; Body Composition; Body Weight; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Fatty Acids, Omega-3; Female; Glycated Hemoglobin; Humans; Insulin; Lipids; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Quality of Life; Trastuzumab; Xerostomia | 2019 |
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Cytokines; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Injections, Subcutaneous; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Stomatitis; Survival Rate; Xerostomia | 2009 |
Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
Topics: Amifostine; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Cytoprotection; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Radiotherapy, Conformal; Tomography, X-Ray Computed; Xerostomia | 2002 |
Phase II randomized study of concomitant chemoradiation using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced squamous cell carcinoma of the head and neck.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Paclitaxel; Radiation Injuries; Radiation-Protective Agents; Stomatitis; Xerostomia | 2003 |
Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Injections, Subcutaneous; Male; Middle Aged; Mucositis; Paclitaxel; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage; Xerostomia | 2007 |
1 other study(ies) available for paclitaxel and Xerostomia
| Article | Year |
|---|---|
Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Chemoradiotherapy; Dermatitis; Disease-Free Survival; Esophagitis; Female; Humans; Male; Middle Aged; Mucositis; Paclitaxel; Prognosis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salivary Gland Neoplasms; Xerostomia | 2012 |